Department of Medical Biotechnology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
J Cell Biochem. 2017 Dec;118(12):4191-4202. doi: 10.1002/jcb.26130. Epub 2017 Jun 13.
Stroke has been emerged as one of major health problems for women worldwide. Increasing of knowledge in this field has provided new data in this area which contribute to finding of new risk factors and could improve stroke treatment. A large number studies indicated a variety of risk factors including sex, age, race, smoking, diabetes, and physical inactivity could be involved in stroke in women. The understanding of various aspects involved in women stroke including risk factors, outcomes, stroke recovery, and prevention could provide new therapeutic platforms which could likely lead to better treatment in women stroke. Diagnosis is one of important steps in stroke therapy. It has been showed that a variety of biomarkers such as microRNAs (miRNAs), tPA, and von willebrand factor could be used as therapeutic and diagnostic biomarkers in stroke therapy. Here, we summarized various aspects of stroke in women which could help to recognition risk factors, outcomes, care, treatment, and novel biomarkers involve in treatment of stroke. J. Cell. Biochem. 118: 4191-4202, 2017. © 2017 Wiley Periodicals, Inc.
中风已成为全球女性的主要健康问题之一。该领域知识的增加提供了该领域的新数据,有助于发现新的危险因素,并改善中风的治疗。大量研究表明,多种危险因素,包括性别、年龄、种族、吸烟、糖尿病和身体活动不足,可能与女性中风有关。了解女性中风的各个方面,包括危险因素、结局、中风恢复和预防,可以提供新的治疗平台,可能会导致更好的女性中风治疗。诊断是中风治疗的重要步骤之一。已经表明,多种生物标志物,如 microRNAs(miRNAs)、tPA 和 von Willebrand 因子,可用作中风治疗的治疗和诊断生物标志物。在这里,我们总结了女性中风的各个方面,这有助于识别危险因素、结局、护理、治疗和新的治疗生物标志物。J. 细胞。生物化学。118:4191-4202, 2017. © 2017 威利父子公司